Bleeding Disorders AND Thrombocytopenia — Written Clinical Reasoning · Phys Written Answers

Prompt

DCE-style written reasoning for Bleeding Disorders AND Thrombocytopenia.

SAQ 1 — Integrated plan (12 marks)

Prompt: Provide a prioritised problem list and management sequence for this presentation. [1] [2]

Model Answer

1. Frame and red flags (3 marks) [1]

State the working diagnosis/syndrome, acuity, and what would force emergency treatment now. [1] [2]

2. Discriminating assessment (3 marks) [2]

List the key history, examination and investigations that separate dangerous differentials from benign mimics. [1] [2]

3. Treatment sequence (4 marks) [1] [3]

Immediate stabilisation, disease-specific therapy, monitoring, and complications prevention. [1] [2] [3]

4. Follow-up and communication (2 marks) [2]

Disposition, safety-net advice, and who owns follow-up. [1] [2]

SAQ 2 — Exam trap defence (8 marks)

Prompt: Name two high-yield traps in Bleeding Disorders AND Thrombocytopenia and how you avoid them. [1] [2]

Model Answer

Trap one: delayed escalation of a high-risk feature — avoid by explicit red-flag checklist. [1]

Trap two: therapy mismatched to mechanism — avoid by confirming the discriminating test before escalating treatment. [2] [3]

References

[1]Ahn SY, Hong J, Kim JS, Kim SH, et al. Korean expert consensus on the management of thrombotic thrombocytopenic purpura Korean J Intern Med, 2026.PMID 42438901
[2]Bierlein JG, Kurosch M, Mager R, Sasca D, et al. Acute hemophagocytic lymphohistiocytosis in a patient treated for stone removal via percutaneous nephrolithotomy: a case report and literature review Int J Surg Case Rep, 2026.PMID 42416426
[3]Banerjee P, Allsup D, Uglow E, Hauff C, et al. A case of immune thrombocytopenia complicated by catastrophic antiphospholipid antibody syndrome and subsequent intramuscular haemorrhage J Med Case Rep, 2026.PMID 42415122
[4]Zhou X, Liu Y, Zhang P, Shan N Precision targeting of CD38 in immune thrombocytopenia: Mechanistic foundations and therapeutic implications Eur J Pharmacol, 2026.PMID 41905452
[5]Mingot-Castellano ME, Álvarez Román MT, Bastida JM, Butta N, et al. Navigating the Hemostatic Balance: Anticoagulation and Antiplatelet Therapy in Patients with Thrombocytopenia J Clin Med, 2026.PMID 41899195
[6]Doan HN, Chang MC Comparative Effectiveness of Unstable Versus Stable Resistance Training on Lower Limb Strength, Mobility, and Fear of Falling in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials Am J Phys Med Rehabil, 2026.PMID 42468010
[7]Liu HW, Tsai TL Virtual Reality-assisted Physiotherapeutic Training for Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis Am J Phys Med Rehabil, 2026.PMID 42468005
[8]Osborne AK, Brown RD, Sillence E Effects of Social Media Narratives on Affective and Behavioral Responses to Menopause Content: Randomized Online Experimental Study JMIR Form Res, 2026.PMID 42467962

SAQ 1 — Integrated plan (12 marks)

Prompt: Provide a prioritised problem list and management sequence for this presentation. [1] [2]

Model Answer

1. Frame and red flags (3 marks) [1]

State the working diagnosis/syndrome, acuity, and what would force emergency treatment now. [1] [2]

2. Discriminating assessment (3 marks) [2]

List the key history, examination and investigations that separate dangerous differentials from benign mimics. [1] [2]

3. Treatment sequence (4 marks) [1] [3]

Immediate stabilisation, disease-specific therapy, monitoring, and complications prevention. [1] [2] [3]

4. Follow-up and communication (2 marks) [2]

Disposition, safety-net advice, and who owns follow-up. [1] [2]

SAQ 2 — Exam trap defence (8 marks)

Prompt: Name two high-yield traps in Bleeding Disorders AND Thrombocytopenia and how you avoid them. [1] [2]

Model Answer

Trap one: delayed escalation of a high-risk feature — avoid by explicit red-flag checklist. [1]

Trap two: therapy mismatched to mechanism — avoid by confirming the discriminating test before escalating treatment. [2] [3]

References

[1]Ahn SY, Hong J, Kim JS, Kim SH, et al. Korean expert consensus on the management of thrombotic thrombocytopenic purpura Korean J Intern Med, 2026.PMID 42438901
[2]Bierlein JG, Kurosch M, Mager R, Sasca D, et al. Acute hemophagocytic lymphohistiocytosis in a patient treated for stone removal via percutaneous nephrolithotomy: a case report and literature review Int J Surg Case Rep, 2026.PMID 42416426
[3]Banerjee P, Allsup D, Uglow E, Hauff C, et al. A case of immune thrombocytopenia complicated by catastrophic antiphospholipid antibody syndrome and subsequent intramuscular haemorrhage J Med Case Rep, 2026.PMID 42415122
[4]Zhou X, Liu Y, Zhang P, Shan N Precision targeting of CD38 in immune thrombocytopenia: Mechanistic foundations and therapeutic implications Eur J Pharmacol, 2026.PMID 41905452
[5]Mingot-Castellano ME, Álvarez Román MT, Bastida JM, Butta N, et al. Navigating the Hemostatic Balance: Anticoagulation and Antiplatelet Therapy in Patients with Thrombocytopenia J Clin Med, 2026.PMID 41899195
[6]Doan HN, Chang MC Comparative Effectiveness of Unstable Versus Stable Resistance Training on Lower Limb Strength, Mobility, and Fear of Falling in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials Am J Phys Med Rehabil, 2026.PMID 42468010
[7]Liu HW, Tsai TL Virtual Reality-assisted Physiotherapeutic Training for Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis Am J Phys Med Rehabil, 2026.PMID 42468005
[8]Osborne AK, Brown RD, Sillence E Effects of Social Media Narratives on Affective and Behavioral Responses to Menopause Content: Randomized Online Experimental Study JMIR Form Res, 2026.PMID 42467962